Common use of Addresses Clause in Contracts

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker Therapeutics, Inc., 3000 Xxxxxxxxx Xxxxxxx, Xxxxx 0000, Xxxxxxx, Xxxxx 00000, Attention: Chief Executive Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker TherapeuticsCytokinetics, Inc.Incorporated, 3000 Xxxxxxxxx Xxxxxxx000 Xxxx Xxxxx Xxxxxx, Xxxxx 0000Xxx Xxxxxxxxx, Xxxxxxx, Xxxxx XX 00000, Attention: Chief Executive Officer [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker CymaBay Therapeutics, Inc., 3000 Xxxxxxxxx XxxxxxxInc. 0000 Xxxxxxx Xxxx., Xxxxx 0000000, XxxxxxxXxxxxx, Xxxxx Xxxxxxxxxx 00000, Attention: Chief Executive Officer [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker TherapeuticsImmunovant, Inc., 3000 Xxxxxxxxx Xxxxxxx000 Xxxx 00xx Xxxxxx, Xxxxx 0000Xxx Xxxx, Xxxxxxx, Xxxxx XX 00000, Attention: Chief Executive Officer [•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker TherapeuticsWxx.xxx Group, Inc., 3000 Xxxxxxxxx Xxxxxxx10000 Xxxx Xxx Xxxxxxx Xxxx, Xxxxx 0000Xxxxxxxxxxxx, Xxxxxxx, Xxxxx Xxxxxxx 00000, Attention: Chief Executive Officer [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●·], Attention: [●·] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker Protagonist Therapeutics, Inc., 3000 Xxxxxxxxx Xxxxxxx0000 Xxxxxxx Xxxx., Xxxxx 0000000, XxxxxxxXxxxxx, Xxxxx XX 00000, Attention: Chief Executive Officer [·] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker ImmunoCellular Therapeutics, Inc.Ltd., 3000 Xxxxxxxxx Xxxxxxx00000 Xxxxxxx Xxxxxxxxx, Xxxxx 00000xx Xxxxx, XxxxxxxXxxxxxxx Xxxxx, Xxxxx Xxxxxxxxxx 00000, Attention: Chief Executive Officer [•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker Allogene Therapeutics, Inc., 3000 Xxxxxxxxx Xxxxxxx000 Xxxx Xxxxx Xxxxxx, Xxxxx 0000Xxx Xxxxxxxxx, Xxxxxxx, Xxxxx Xxxxxxxxxx 00000, Attention: Chief Executive Officer [•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker TherapeuticsImmunovant, Inc., 3000 Xxxxxxxxx Xxxxxxx000 Xxxx 00xx Xxxxxx, Xxxxx 0000Xxx Xxxx, Xxxxxxx, Xxxxx XX 00000, Attention: Chief Executive Officer [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker TherapeuticsZIOPHARM Oncology, Inc., 3000 Xxxxxxxxx XxxxxxxOne First Avenue, Xxxxx 0000Xxxxxx Building 00, XxxxxxxXxxx Xxxx Xxxxx, Xxxxx Xxxxxx, Xxxxxxxxxxxxx 00000, Attention: Chief Executive Officer [•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●—], Attention: [●—] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker TherapeuticsMedivation, Inc., 3000 Xxxxxxxxx Xxxxxxx000 Xxxxx Xxxxxx, Xxxxx 00000xx Xxxxx, XxxxxxxXxx Xxxxxxxxx, Xxxxx Xxxxxxxxxx 00000, Attention: Chief Executive Officer [—] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker ImmunoCellular Therapeutics, Inc.Ltd., 3000 00000 Xxxxxxxxx XxxxxxxXxxx, Xxxxx 0000000, XxxxxxxXxxxxxxxx, Xxxxx Xxxxxxxxxx 00000, Attention: Chief Executive Officer [•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker Xxxx Therapeutics, Inc., 3000 Xxxxxxxxx Xxxxxxx0000 Xxxxxx Xxxxxxxxx, Xxxxx 0000000, XxxxxxxXxxxxxxx, Xxxxx XX 00000, Attention: Chief Executive Officer [•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●—], Attention: [●—] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker TherapeuticsZIOPHARM Oncology, Inc., 3000 Xxxxxxxxx XxxxxxxOne First Avenue, Xxxxx 0000Xxxxxx Building 00, XxxxxxxXxxx Xxxx Xxxxx, Xxxxx Xxxxxx, Xxxxxxxxxxxxx 00000, Attention: Chief Executive Officer [—] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●¨], Attention: [●¨] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker TherapeuticsCytokinetics, Inc.Incorporated, 3000 Xxxxxxxxx Xxxxxxx000 Xxxx Xxxxx Xxxxxx, Xxxxx 0000Xxx Xxxxxxxxx, Xxxxxxx, Xxxxx Xxxxxxxxxx 00000, Attention: Chief Executive Officer [¨] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●·], Attention: [●·] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker Therapeutics, Resonant Inc., 3000 000 Xxxxxxxxx XxxxxxxXxxxx, Xxxxx 0000000, XxxxxxxXxxxxx, Xxxxx Xxxxxxxxxx 00000, Attention: Chief Executive Officer [·] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker TherapeuticsImmunome, Inc., 3000 Xxxxxxxxx Xxxxxxx600 Xxxxxxxx Xxxxx, Xxxxx 0000000, XxxxxxxXxxxx, Xxxxx XX 00000, Attention: Chief Executive Officer [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker TherapeuticsCytokinetics, Inc., 3000 Xxxxxxxxx XxxxxxxIncorporated 000 Xxxx Xxxxx Xxxxxx, Xxxxx 0000Xxx Xxxxxxxxx, Xxxxxxx, Xxxxx XX 00000, Attention: Chief Executive Officer [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker Protagonist Therapeutics, Inc., 3000 Xxxxxxxxx XxxxxxxInc. 0000 Xxxxxxx Xxxxxxxxx, Xxxxx 0000000, XxxxxxxXxxxxx, Xxxxx Xxxxxxxxxx 00000, Attention: Chief Executive Officer [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker TherapeuticsTerrAscend Corp., Inc., 3000 Xxxxxxxxx Xxxxxxx00 Xxxx Xxxxxx Xxxxx, Xxxxx 0000000—Xxxx Xxxxx, Xxxxxxxxxxx, Xxxxxxx, Xxxxx 00000X0X 0X0, Xxxxxx, Attention: [Xxxx Xxxxx, Chief Executive Officer Legal Officer] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●—], Attention: [●—] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker TherapeuticsCytokinetics, Inc.Incorporated, 3000 Xxxxxxxxx Xxxxxxx000 Xxxx Xxxxx Xxxxxx, Xxxxx 0000Xxx Xxxxxxxxx, Xxxxxxx, Xxxxx Xxxxxxxxxx 00000, Attention: Chief Executive Officer [—] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker TherapeuticsCytokinetics, Inc.Incorporated, 3000 Xxxxxxxxx Xxxxxxx, Xxxxx 0000, Xxxxxxx, Xxxxx 00000, Attention: Chief Executive Financial Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker TherapeuticsCytokinetics, Inc.Incorporated, 3000 Xxxxxxxxx Xxxxxxx000 Xxxx Xxxxx Xxxxxx, Xxxxx 0000Xxx Xxxxxxxxx, Xxxxxxx, Xxxxx Xxxxxxxxxx 00000, Attention: Chief Executive Officer [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●—], Attention: [●—] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker TherapeuticsIdentive Group, Inc., 3000 Xxxxxxxxx Xxxxxxx00000 Xxxxx Xxxxxx Xxxxx, Xxxxx 0000000, Xxxxxxx, Xxxxx Xxxxxxxxxx 00000, Attention: Chief Executive Officer [—] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker Gain Therapeutics, Inc., 3000 Xxxxxxxxx XxxxxxxInc. 0000 Xxxxxxx Xxxx, Xxxxx 0000000, XxxxxxxXxxxxxxx, Xxxxx XX 00000, Attention: Chief Executive Officer [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker TherapeuticsMxxxxx Automotive Inc. 1000 Xxxxxxx Xxxxxx, Inc.Xxxx, 3000 Xxxxxxxxx Xxxxxxx, Xxxxx 0000, Xxxxxxx, Xxxxx Xxxxxxxxxx 00000, Attention: Chief Executive Officer [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker TherapeuticsCytokinetics, Inc.Incorporated, 3000 Xxxxxxxxx Xxxxxxx000 Xxxxxx Xxxxx Xxxxxxxxx, Xxxxx 0000Xxx Xxxxxxxxx, Xxxxxxx, Xxxxx 00000, Attention: Chief Executive Financial Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker TherapeuticsCytokinetics, Inc.Incorporated, 3000 Xxxxxxxxx Xxxxxxx000 Xxxxxx Xxxxx Xxxxxxxxx, Xxxxx 0000Xxx Xxxxxxxxx, XxxxxxxXxxxxxxxxx, Xxxxx 00000, Attention: Chief Executive Financial Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker TherapeuticsXxx.xxx Group, Inc., 3000 Xxxxxxxxx Xxxxxxx00000 Xxxx Xxx Xxxxxxx Xxxx, Xxxxx 0000Xxxxxxxxxxxx, Xxxxxxx, Xxxxx XX 00000, Attention: Chief Executive Officer [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker TherapeuticsIdentive Group, Inc., 3000 Xxxxxxxxx Xxxxxxx00000 Xxxxx Xxxxxx Xxxxx, Xxxxx 0000000, Xxxxxxx, Xxxxx Xxxxxxxxxx 00000, Attention: Chief Executive Officer [•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker TherapeuticsCytokinetics, Inc.Incorporated, 3000 Xxxxxxxxx Xxxxxxx000 Xxxxxx Xxxxx Xxxxxxxxx, Xxxxx 0000Xxx Xxxxxxxxx, Xxxxxxx, Xxxxx Xxxxxxxxxx 00000, Attention: Chief Executive Financial Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], , Attention: [●] , and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker TherapeuticsCytokinetics, Inc.Incorporated, 3000 Xxxxxxxxx Xxxxxxx000 Xxxx Xxxxx Xxxxxx, Xxxxx 0000Xxx Xxxxxxxxx, Xxxxxxx, Xxxxx XX 00000, Attention: Chief Executive Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Marker TherapeuticsIdentive Group, Inc., 3000 Xxxxxxxxx Xxxxxxx00000 Xxxxx Xxxxxx Xxxxx, Xxxxx 0000000, Xxxxxxx, Xxxxx XX 00000, Attention: Chief Executive Officer [•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).